Clinical Trials in Egypt / NCT07138768
Recruiting
Observational
Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings
NCT07138768 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Magnetic Resonance ImagingDiagnosisManagementAcute StrokeTurnaround TimeEmergency Settings
Investigational drug(s) / intervention(s)
Magnetic Resonance Imaging
Magnetic Resonance Imaging: Magnetic Resonance Imaging will be performed to all patients
Study summary
This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.
Eligibility
Inclusion Criteria:
* Age ≥18 years.
* Both sexes.
* Patients with acute stroke who are admitted to the emergency department.
Exclusion Criteria:
* Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT).
* Symptoms strongly suggestive of subarachnoid hemorrhage.
* Initiation of antithrombotic or thrombolytic treatment before the completion of both scans.
* Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms.
* Uncontrollable hypertension.
* Pregnant or lactating women.
Primary outcome measure(s)
- Sensitivity of magnetic resonance imaging for acute stroke — Immediately post-procedure (Up to 1 hour)
Sensitivity of magnetic resonance imaging for acute stroke will be recorded.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Tanta University | Tanta | El-Gharbia | Recruiting |
More Tanta University trials in Egypt
Other trials for the same condition
Isolated Versus Synergetic Muscle Facilitation on Upper Limb Functional Performance in Acute Stroke
Recruiting
Non-invasive Diffusion-weighted Imaging With MRCP in the Diagnosis of Neoplastic Biliary Obstruction
Recruiting
mSOAR and Early Mortality in Acute Stroke
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07138768 on ClinicalTrials.gov ↗ ← All trials in Egypt